Thomas H. JenningsManaging Director
Tom joined Summit Partners in 1997 as an Associate and today, as a Managing Director, co-heads the firm’s venture capital team.
Tom is currently a director of Accedian Networks, ApoCell, AvePoint, Clarabridge, NetBrain Technologies, PeerApp, Telerik and Zenoss and is actively involved with the firm’s investments in Casa Systems, Logi Analytics and NameMedia. Tom’s prior investments and directorships include Anesthetix (acquired by TeamHealth), Burst Media Corporation (AIM: BRST, later acquired by blinkx PLC), Commnet Wireless (acquired by Atlantic Tele-Network, Inc.), Fermentas International (acquired by Thermo Fisher Scientific), Hatcher Associates (acquired by Corillian Corporation), Hiperos (acquired by Opus Global), Immco Diagnostics (acquired by Trinity Biotech), My Dentist Holdings (acquired by Heartland Dental Care), NetWitness Corporation (acquired by EMC Corporation), OB Hospitalist Group (acquired by Ares Management), Sage Telecom and Unica Corporation (NASDAQ: UNCA, later acquired by IBM).
Prior to Summit, Tom worked as a consultant with Andersen Consulting (now Accenture). He holds an AB in economics and theology from Boston College, where he received the Scholar of the College award.
Tom is a Trustee of the Massachusetts Soldiers Legacy Fund, an organization that provides tuition funding for the children of fallen service members from Massachusetts.